News Archive - Page 8 of 131 - Life Sciences Scotland

Filter by Date

Clear

New cancer drug discovery partnership announced

The University of Dundee has announced a new partnership with Eisai, one of the world’s leading research-based pharmaceutical companies, aiming...

8th Jul 2019

Cobra Biologics and Symbiosis Complete £4.8M Viral Vector Supply Chain Collaboration

Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) focused on viral vector drug substance production, and Symbiosis...

27th Jun 2019

NuCana Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Acelarin® for the Treatment of Biliary Tract Cancer

NuCana plc (NASDAQ: NCNA) announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the...

13th Jun 2019

UK Steel Enterprise seals deal with Scots firm Antibody Analytics

UK Steel Enterprise has provided more than £100 million of financial support to aspiring businesses across the UK following its...

13th Jun 2019

Bid to beat superbugs aided by immune discovery

The fight against superbugs could be helped by the discovery of a potential therapy based on the body’s natural immune...

3rd Jun 2019

Dorian Therapeutics Accesses Novel Compound Library from Ubiquigent

Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system-focused drug discovery, announced today that it had entered into...

23rd May 2019

Do you have news for the Scottish Life Sciences Community?

Submit Your Own News